[1]TetrahedronLetters,2003,vol.44,p.8697-8700
[2]JournalofMedicinalChemistry,2001,vol.44,p.3856-3871
[3]Patent:WO2013/26914,2013,A1.Locationinpatent:Page/Pagecolumn100
[4]Patent:WO2017/12647,2017,A1.Locationinpatent:Paragraph0570
3996-39-2 | 2-(3-Bromophenyl)ethanethioic O-acid | AA00CQTO | MFCD09040613
344323-24-6 | 1,3-Butanediamine,N1,N1,2-trimethyl-(9CI) | AA00CRJS | MFCD18805496
37470-58-9 | Ethyl 3-bromo-4-hydroxybenzoate | AA00CU67 | MFCD06204654
338965-51-8 | 3-(4-Fluorobenzyloxy)-2-methyl-1H-pyridin-4-one | AA00CW66 | MFCD00215663
38399-46-1 | 4-formyl-3-hydroxynaphthalene-2-carboxylic acid | AA00CYMI | MFCD00449857
31676-48-9 | 7-PHENYLINDOLIN-2-ONE | AA00D0AK | MFCD10699554
35991-93-6 | 4-(1-naphthoxy)-3-hydroxybutyramide oxime hydrochloride | AA00D2CS | MFCD01737036
337910-17-5 | 3-(1-Benzylpiperidin-4-yl)-3,4-dihydroquinazolin-2-amine | AA00D4MA | MFCD25948725
372075-75-7 | 3-trifluoromethyl-1-methyl-1H-5-chloroPyrazole | AA00D5HA | MFCD03409451
42069-01-2 | O-Ethyl s-propyl chlorodithiophosphate | AA00D738 | MFCD10566401